Treatment of maternal syphilis for preventing congenital syphilis: an observational study of adherence to treatment recommendation in Suzhou, China, 2019–2021
Xing-Fan Mo A B # , Ming-Zhi Feng A B # , Ting-Ting Jiang
C D , Ya-Ting Xu A B , Min-Juan Wu A B , Jing-Jing Li A B , Min-Zhi Wu A B * , Yue-Ping Yin C D and Xiang-Sheng Chen C D *
A
B
C
D
Handling Editor: Matthew Hogben
Sexual Health - https://doi.org/10.1071/SH23082
Submitted: 28 April 2023 Accepted: 13 September 2023 Published online: 2 October 2023
Abstract
China is one of the countries that set the goal to eliminate mother-to-child transmission (EMTCT) of syphilis by a target date. Active screening for syphilis among pregnant women, followed by effective treatment of maternal syphilis, is critical for achieving the goal. The China health authority issued national implementation protocols to guide EMTCT practice in health facilities.
Within a cohort of infants born to mothers infected with syphilis, we obtained the data of regimens used for treatment of maternal syphilis from the National Information System of Prevention of Mother-to-Child Transmission of HIV, Syphilis and Hepatitis B, and analysed the physician’s treatment behaviour and its associated factors in a public hospital in Suzhou of China.
A total of 450 pregnant women who were positive for treponemal or non-treponemal antibody, or had previous infection with syphilis were included into the study for analysis. Of them, 260 (57.8%) were positive for both treponemal and non-treponemal antibodies (syphilis seropositivity), and 353 (78.4%) were treated for syphilis according to the protocol in which 123 (34.8%) were treated with two courses. Non-adherence to treatment recommended by the protocol for maternal syphilis was significantly associated with antenatal visits in the third trimester (AOR 6.65, 95% CI 2.20–20.07, P = 0.001), being positive only for a treponemal test (AOR 5.34, 95% CI 3.07–9.29, P < 0.001) or having a syphilis infection before the pregnancy (AOR 2.05, 95% CI 1.14–3.69, P = 0.017), whereas the uptake of treatment for two treatment courses was associated with attending antenatal care in 2020 or before (AOR 3.49, 95% CI 1.89–6.42, P < 0.001), being positive for treponemal and non-treponemal tests (AOR 5.28, 95% CI 2.78–10.06, P < 0.001) or having non-treponemal antibody titre of ≥1:8 (AOR 3.71, 95% CI 1.77–7.78, P = 0.001).
Implementation of the current recommendation to offer a universal treatment for syphilis among all pregnant women who are shown to be positive for a treponemal test alone is challenging in some clinical settings in China.
Keywords: antenatal care, antibody titre, clinical setting, congenital syphilis, maternal syphilis, treatment guideline, non-adherence, treatment adherence.
References
2 Newman L, Kamb M, Hawkes S, et al. Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Med 2013; 10: e1001396.
| Crossref | Google Scholar | PubMed |
3 Hawkes S, Matin N, Broutet N, Low N. Effectiveness of interventions to improve screening for syphilis in pregnancy: a systematic review and meta-analysis. Lancet Infect Dis 2011; 11: 684-91.
| Crossref | Google Scholar | PubMed |
4 Qin J, Yang T, Xiao S, Tan H, Feng T, Fu H. Reported estimates of adverse pregnancy outcomes among women with and without syphilis: a systematic review and meta-analysis. PLoS One 2014; 9: e102203.
| Crossref | Google Scholar | PubMed |
5 WHO. The global elimination of congenital syphilis: rationale and strategy for action. Geneva: World Health Organization; 2007. Available at https://www.who.int/publications/i/item/9789241595858 [accessed 19 October 2022]
6 Korenromp EL, Rowley J, Alonso M, et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes – estimates for 2016 and progress since 2012. PLoS ONE 2019; 14: e0211720.
| Crossref | Google Scholar |
7 China NHFPC. Notice of the General Office of the National Health and Family Planning Commission on comprehensively carrying out the prevention of mother-to-child transmission of AIDS, syphilis and hepatitis B (in Chinese). Beijing: National Health and Family Planning Commission of the People’s Republic of China; 2015. Available at http://www.nhc.gov.cn/fys/s3581/201506/4f2123fa955a44afa75a75da2ad35d6e.shtml [accessed 19 October 2022]
8 China NHC. Announcement on the Public Solicitation of Comments on the Work Specification for the Prevention of Mother-to-Child Transmission of HIV/AIDS, Syphilis and Hepatitis B (2020 Edition) (Draft for Comments) (in Chinese). Beijing: National Health Commission of the People’s Republic of China; 2020. Available at http://www.nhc.gov.cn/fys/s3582/202007/ba48eea5e52f4fb1b73b066fddd47015.shtml [accessed 19 October 2022]
11 Jiang N, Gong X, Yue X. Estimation of syphilis epidemic through application of workbook method among populations aged from 15 to 49 years old in China in 2011 (in Chinese). Chin J Prev Med 2014; 48: 693-8.
| Google Scholar |
12 Chen X-S, Jiang T-T, Yin Y-P, Wang Q-Q. The past 70 years in control of syphilis in China: elimination and responses to resurgence. Int J Dermato Venereo 2020; 3: 193-7.
| Crossref | Google Scholar |
13 Chen X-S. Challenges in responses to syphilis epidemic. Lancet Infect Dis 2017; 17(8): 793-4.
| Crossref | Google Scholar | PubMed |
14 World Health Organization. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus. Geneva: WHO; 2022. Available at https://www.who.int/publications/i/item/9789240039360 [accessed 19 October 2022]
15 Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021; 70: 1-187.
| Crossref | Google Scholar | PubMed |
16 Kingston M, French P, Higgins S, et al. UK national guidelines on the management of syphilis 2015. Int J STD AIDS 2016; 27: 421-46.
| Crossref | Google Scholar | PubMed |
17 Torres RG, Mendonça ALN, Montes GC, Manzan JJ, Ribeiro JU, Paschoini MC. Syphilis in pregnancy: the reality in a public hospital. Rev Bras Ginecol Obstet 2019; 41: 90-6.
| Crossref | Google Scholar | PubMed |
18 Hong F-C, Wu X-B, Yang F, et al. Risk of congenital syphilis (CS) following treatment of maternal syphilis: results of a CS control program in China. Clin Infect Dis 2017; 65: 588-94.
| Crossref | Google Scholar | PubMed |
19 Srikantiah P. Elimination of new paediatric HIV infections and congenital syphilis in Asia-Pacific, 2011–2015: conceptual framework & monitoring and evaluation guide. Bangkok: UNICEF East Asia and Pacific Regional Office; 2011. Available at https://static.wixstatic.com/ugd/98aff9_cf1fc461b8fd475e84ed99c1e9633e95.pdf [accessed 19 October 2022]
20 Chang SN, Chung KY, Lee MG, Lee JB. Seroreversion of the serological tests for syphilis in the newborns born to treated syphilitic mothers. Sex Transm Infect 1995; 71: 68-70.
| Crossref | Google Scholar | PubMed |
21 Hira SK, Bhat GJ, Chikamata DM, et al. Syphilis intervention in pregnancy: Zambian demonstration project. Sex Transm Infect 1990; 66: 159-64.
| Crossref | Google Scholar | PubMed |
22 Watson-Jones D, Changalucha J, Gumodoka B, et al. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis 2002; 186: 940-7.
| Crossref | Google Scholar | PubMed |
23 Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ 2013; 91: 217-26.
| Crossref | Google Scholar | PubMed |
24 Han Y, Yin Y-P, Zhou Y, et al. Nonadherence to national guidelines for antibiotic treatment of uncomplicated gonorrhea in China: results from a nationwide survey. Sex Transm Dis 2018; 45: 600-6.
| Crossref | Google Scholar | PubMed |
